Treatment options for non-motor symptoms in late-stage Parkinson's disease

By Coelho Miguel   Ferreira Joaquim   Rosa Mrio   Sampaio Cristina  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 4, 2008-03 ,pp. : 523-535

Informa Healthcare

Access to resources Recommend Favorite

The Src-Induced Mesenchymal State in Late-Stage Colon Cancer Cells

By  

Cells Tissues Organs, Vol. 179, Iss. 1-2, 2005-06 ,pp. : 73-80

Karger

Access to resources Recommend Favorite

A Phase II study of bosentan, a dual endothelin receptor antagonist, as monotherapy in patients with stage IV metastatic melanoma

By Kefford Richard   Beith Jane   Hazel Guy   Millward Michael   Trotter James   Wyld David   Kusic Rada   Shreeniwas Revati   Morganti Adele   Ballmer Andrea   Segal Eleonor   Nayler Oliver   Clozel Martine  

Investigational New Drugs, Vol. 25, Iss. 3, 2007-06 ,pp. : 247-252

Springer Publishing Company

Access to resources Recommend Favorite

Increased plasma budesonide concentrations in late-stage PBC may be associated with serious adverse events

By  

Inpharma, Vol. 1, Iss. 1399, 2003-01 ,pp. : 20-20

Adis International

Access to resources Recommend Favorite

Reduction in late-stage breast cancer incidence in the mammography era: Implications for overdiagnosis of invasive cancer

By Helvie Mark A.   Chang Joanne T.   Hendrick R. Edward   Banerjee Mousumi  

Cancer, Vol. 120, Iss. 17, 2014-09 ,pp. : 2649-2656

Blackwell Publishing

Access to resources Recommend Favorite